Skandinaviska Enskilda Banken (SEB)
MLAB icon

Skandinaviska Enskilda Banken (SEB)’s Mesa Laboratories MLAB Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,100
Closed -$1.45M – 982
2022
Q2 		$1.45M Hold
7,100
– – 0.01% 643
2022
Q1 		$1.81M Buy
7,100
+900
+15% +$244K 0.01% 641
2021
Q4 		$2.06M Buy
6,200
+2,200
+55% +$691K 0.01% 644
2021
Q3 		$1.21M Buy
+4,000
New +$1.14M 0.01% 757
2021
Q2 		– Sell
-1,500
Closed -$365K – 1103
2021
Q1 		$365K Buy
+1,500
New +$413K ﹤0.01% 967

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s MLAB Position: Q3 2022 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Mesa Laboratories (MLAB) in Q3 2022, closing a stake of 7,100 shares — an estimated $1.45M sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in MLAB in Q1 2021 and held it in 5 quarters. The position peaked at $2.06M in Q4 2021. 163 funds tracked by Wall St. Rank hold MLAB as of Q3 2022.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Mesa Laboratories position as of Q3 2022 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 7,100 Mesa Laboratories shares in Q3 2022, an estimated $1.45M.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Mesa Laboratories in Q1 2021 and held it in 5 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Mesa Laboratories position peaked at $2.06M in Q4 2021.
  • 163 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2022.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q3 2022, filed 14 Nov 2022.